A Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality.

MLA

Verma, Anurag, et al. “A Gene Polymorphism, Rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality.” American Journal of Respiratory & Critical Care Medicine, vol. 206, no. 10, Nov. 2022, pp. 1220–29. EBSCOhost, https://doi.org/10.1164/rccm.202109-2166OC.

APA

Verma, A., Minnier, J., Wan, E. S., Huffman, J. E., Gao, L., Joseph, J., Yuk-Lam Ho, Wen-Chih Wu, Cho, K., Gorman, B. R., Rajeevan, N., Pyarajan, S., Garcon, H., Meigs, J. B., Sun, Y. V., Reaven, P. D., McGeary, J. E., Ayako Suzuki, Gelernter, J., & Lynch, J. A. (2022). A Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality. American Journal of Respiratory & Critical Care Medicine, 206(10), 1220–1229. https://doi.org/10.1164/rccm.202109-2166OC

Chicago

Verma, Anurag, Jessica Minnier, Emily S. Wan, Jennifer E. Huffman, Lina Gao, Jacob Joseph, Yuk-Lam Ho, et al. 2022. “A Gene Polymorphism, Rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality.” American Journal of Respiratory & Critical Care Medicine 206 (10): 1220–29. doi:10.1164/rccm.202109-2166OC.